Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
bone diseases
MeSH D001847 - bone diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009140:
Musculoskeletal diseases
0 Companies
0 Drugs
Success rate
D001847:
Bone diseases
6 Companies
1 Drug
$
Success rate
D000070603:
Coxa magna
0 Companies
0 Drugs
Success rate
D001845:
Bone cysts
0 Companies
0 Drugs
Success rate
D001848:
Developmental bone diseases
0 Companies
0 Drugs
Success rate
D001849:
Endocrine bone diseases
0 Companies
0 Drugs
Success rate
D001850:
Infectious bone diseases
85 Companies
26 Drugs
$
Success rate
D001851:
Metabolic bone diseases
0 Companies
0 Drugs
Success rate
D001859:
Bone neoplasms
29 Companies
1 Drug
$
Success rate
D001862:
Bone resorption
2 Companies
1 Drug
$
Success rate
D004803:
Eosinophilic granuloma
0 Companies
0 Drugs
Success rate
D004839:
Slipped epiphyses
0 Companies
0 Drugs
Success rate
D010000:
Osteitis
0 Companies
0 Drugs
Success rate
D010001:
Osteitis deformans
3 Companies
1 Drug
$
Success rate
D010004:
Primary hypertrophic osteoarthropathy
0 Companies
0 Drugs
Success rate
D010005:
Secondary hypertrophic osteoarthropathy
0 Companies
0 Drugs
Success rate
D010007:
Osteochondritis
0 Companies
0 Drugs
Success rate
D010020:
Osteonecrosis
0 Companies
0 Drugs
Success rate
D013122:
Spinal diseases
0 Companies
0 Drugs
Success rate
D015576:
Hyperostosis
0 Companies
0 Drugs
Success rate
D017760:
Bone malalignment
0 Companies
0 Drugs
Success rate
D055034:
Osteochondrosis
0 Companies
0 Drugs
Success rate
D056304:
Genu valgum
0 Companies
0 Drugs
Success rate
D056305:
Genu varum
0 Companies
0 Drugs
Success rate
D060906:
Coxa valga
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
50
%
3/6
Phase 2
63
%
5/8
Phase 3
8
%
1/12
Approved:
1
Overall Success rate:
3%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Novartis
Deferoxamine
,
Etidronic acid
,
Pamidronic acid
,
Risedronic acid
,
Retinol
,
Ccb
,
Bhq880
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use